Did not become law. It stopped in the Senate on March 24, 2016. The 2016 session has ended.
2016 Regular Session
Senate Bill 313
AN ACT CONCERNING BIOLOGICAL PRODUCTS.
What it does
The synopsis the General Assembly published with the bill.
To add biological products to existing law regarding substitution of generic drugs.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
Its course
February 25 to March 24, 2016, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action9 actions on 5 days
In the SenateFeb 25 to Mar 24 · stopped28 days
General Law CommitteeFeb 25 to Mar 1115 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Feb 25 – Mar 11
- Feb 25Introduced and sent to General Law Committee
- Mar 4Heard in General Law Committee
- Mar 11General Law Committee recommended it
All 9 actions, as published
- Feb 25REF. TO JOINT COMM. ONBoth houses
- Mar 4PUBLIC HEARINGBoth houses
- Mar 11Joint FavorableBoth houses
- Mar 11FILED WITH LCOBoth houses
- Mar 18REFERRED TO OLR, OFABoth houses
- Mar 24RPTD. OUT OF LCOBoth houses
- Mar 24FAV. RPT., TAB. FOR CAL., SEN.Senate
- Mar 24SENATE CALENDAR NUMBERSenate
- Mar 24FILE NO.Both houses